Hydrogen-rich water protects against ischemic brain injury in rats by regulating calcium buffering proteins.
Han L, Tian R, Yan H, Pei L, Hou Z, Hao S, Li YV, Tian Q, Liu B, Zhang Q · Brain research · 2015
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

The publication “Hydrogen-rich water protects against ischemic brain injury in rats by regulating calcium buffering proteins.” is organized in H2HUBB under the research focus hydrogen water research study 2015 han. The publication is cited as Han L, Tian R, Yan H, Pei L, Hou Z, Hao S, Li YV, Tian Q, Liu B, Zhang Q, Brain research, 2015. This animal study examined Hydrogen-rich water protects against ischemic brain injury in rats by regulating calcium buffering proteins. The abstract describes Rat model; hydrogen delivered as hydrogen water. The abstract reports: Based on our results, HRW treatment was able to reduce brain infarct volume and improve neurological function following ischemic brain injury. This is an automated editorial draft based on the abstract and requires source review before publication.
Hydrogen water research study 2015 han overview
The aim of this study was to investigate whether HRW could moderate parvalbumin and hippocalcin expression during ischemic brain injury and glutamate toxicity-induced neuronal… Animal research can identify biological effects and support future investigation, but it cannot by itself establish safety or effectiveness in humans.
Study design and hydrogen intervention
Publication type: Animal study. Evidence type: Preclinical animal evidence. Research model or population: Rat model. Blinding: Unknown. Control status: Unknown.
Delivery method: Hydrogen water.
Reported findings and scientific interpretation
For this hydrogen water research study 2015 han, the study record reports the following: The abstract reports: Based on our results, HRW treatment was able to reduce brain infarct volume and improve neurological function following ischemic brain injury.
These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.
How this research record was prepared
H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.
Limitations, safety, and original source
Limitations: Preclinical animal findings may not translate directly to human outcomes.
Safety: The aim of this study was to investigate whether HRW could moderate parvalbumin and hippocalcin expression during ischemic brain injury and glutamate toxicity-induced neuronal…
This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.